JOURNAL BROWSE
Search
Advanced SearchSearch Tips
CYP1A1 MspI Polymorphism and Cervical Carcinoma Risk in the Multi-Ethnic Population of Malaysia: a Case-Control Study
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
CYP1A1 MspI Polymorphism and Cervical Carcinoma Risk in the Multi-Ethnic Population of Malaysia: a Case-Control Study
Tan, Yee Hock; Sidik, Shiran Mohd; Husain, Sharifah Noor Akmal Syed; Lye, Munn Sann; Chong, Pei Pei;
  PDF(new window)
 Abstract
Background: Tobacco smoking is considered a risk factor for cervical cancer development due to the presence of tobacco based carcinogenic metabolites in cervical cells of female smokers. In this study, we investigated the role of the T3801C (MspI) polymorphism of CYP1A1, a gene encoding an enzyme necessary for the initiation of tobacco based carcinogen metabolism, on cervical cancer risk. The T to C substitution may alter CYP1A1 activities, potentially elevating cervical cancer risk. Since results of gene-disease association studies vary according to the study population, the multi-ethnic population of Malaysia provides an excellent representative cohort for identifying and comparing the cervical cancer risk among the 3 major ethnics in Southeast Asia in relation to CYP1A1 MspI polymorphism. Materials and Methods: A total of 195 Thin Prep Pap smear samples from HPV negative and cancer free females were randomly selected as controls while 106 formalin fixed paraffin embedded samples from females with invasive cervical cancer were randomly selected for the cases group. The polymorphisms were identified using restriction fragment length polymorphism (RFLP) PCR. Results: We found no significant associations between CYP1A1 MspI polymorphism and cervical cancer in the general Malaysian female population. However, upon ethnic stratification, the variant C/C genotype was significantly associated with a 4.66-fold increase in cervical cancer risk in Malay females (95% CI
 Keywords
CYP1A1;MspI;cervical cancer;SNP;Malaysia;
 Language
English
 Cited by
 References
1.
Agorastos T, Papadopoulos N, Lambropoulos AF, et al (2007). Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women. Eur J Cancer Prev, 16, 498-504. crossref(new window)

2.
Au WW, Sierra-Torres CH, Tyring SK (2003). Acquired and genetic susceptibility to cervical cancer. Mutat Res, 544, 361-4. crossref(new window)

3.
Autrup H (2000). Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res, 464, 65-76. crossref(new window)

4.
Barbisan G, Contreras A, Perez LO, Difranza L, Golijow CD (2011). The effect of TP53 codon 72 and RNASEL codon 462 polymorphisms on the development of cervical cancer in Argentine women. Cancer Genet, 204, 270-7. crossref(new window)

5.
Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28.

6.
Bartsch H, Petruzzelli S, De Flora S, et al (1992). Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case-control multicenter study on lung cancer patients. Environ Health Perspect, 98, 119-24.

7.
Berber U, Yilmaz I, Yilmaz O, et al (2013). CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population. Asian Pac J Cancer Prev, 14, 3925-9. crossref(new window)

8.
Bonassi S, Au WW (2002). Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res, 511, 73-86. crossref(new window)

9.
Boyapati SM, Shu XO, Gao YT, et al (2005). Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women. Cancer, 103, 2228-35. crossref(new window)

10.
Chen Z, Li Z, Niu X, et al (2011). The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global metaanalysis based on 71 case-control studies. Mutagenesis, 26, 437-46. crossref(new window)

11.
Chong PP, Asyikin N, Rusinahayati M, et al (2010). High prevalence of human papillomavirus DNA detected in cervical swabs from women in southern Selangor, Malaysia. Asian Pac J Cancer Prev, 11, 1645-51.

12.
Crofts F, Taioli E, Trachman J, et al (1994). Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-3. crossref(new window)

13.
Ding G, Xu W, Liu H, et al (2013). CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis. Mol Biol Rep, 40, 3483-91. crossref(new window)

14.
Goodman MT, McDuffie K, Hernandez B, et al (2001). CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol, 81, 263-9. crossref(new window)

15.
Gutman G, Morad T, Peleg B, et al (2009). CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer. Int J Gynecol Cancer, 19, 1300-2. crossref(new window)

16.
Hamzi Abdul Raub S, Isa NM, Zailani HA, et al (2014). Distribution of HPV genotypes in cervical cancer in multiethnic Malaysia. Asian Pac J Cancer Prev, 15, 651-6. crossref(new window)

17.
Hecht SS (1999). DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res, 424, 127-42. crossref(new window)

18.
Hoory T, Monie A, Gravitt P, Wu TC (2008). Molecular epidemiology of human papillomavirus. J Formos Med Assoc, 107, 198-217. crossref(new window)

19.
Islam MS, Ahmed MU, Sayeed MS, et al (2013). Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population. Clin Chim Acta, 416, 11-9. crossref(new window)

20.
Jiang XY, Chang FH, Bai TY, Lv XL, Wang MJ (2014). Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region. Asian Pac J Cancer Prev, 15, 5207-14. crossref(new window)

21.
Joseph T, Chacko P, Wesley R, et al (2006). Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol, 101, 411-7. crossref(new window)

22.
Juarez-Cedillo T, Vallejo M, Fragoso JM, et al (2007). The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism. Eur J Cancer, 43, 1590-5. crossref(new window)

23.
Kim JW, Lee CG, Park YG, et al (2000). Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer, 88, 2082-91. crossref(new window)

24.
Kiyohara C, Hirohata T, Inutsuka S (1996). The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res, 87, 18-24. crossref(new window)

25.
Lee KM, Kang D, Clapper ML, et al (2008). CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev, 17, 1120-6. crossref(new window)

26.
Lim HK, Ghazali SM, Kee CC, et al (2013). Epidemiology of smoking among Malaysian adult males: prevalence and associated factors. BMC Public Health, 13, 8. crossref(new window)

27.
Liu L, Wu G, Xue F, et al (2013). Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers. Eur J Cancer, 49, 2143-51. crossref(new window)

28.
McCann MF, Irwin DE, Walton LA, et al (1992). Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev, 1, 125-9.

29.
Melikian AA, Sun P, Prokopczyk B, et al (1999). Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography mass spectrometry. Cancer Lett, 146, 127-34. crossref(new window)

30.
Nishino K, Sekine M, Kodama S, et al (2008). Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res, 34, 994-1001.

31.
Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. crossref(new window)

32.
Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE (1997). Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst, 89, 868-73. crossref(new window)

33.
Remmink AJ, Walboomers JM, Helmerhorst TJ, et al (1995). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer, 61, 306-11. crossref(new window)

34.
Report of the Global Adult Tobacco Survey (GATS) Malaysia 2011 (2012). Institute for Public Health, National Institute of Health, Ministry of Health, Malaysia. 23,53

35.
Roszak A, Lianeri M, Sowinska A, Jagodzinski PP (2014). CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population. Mol Diagn Ther, 18, 445-50. crossref(new window)

36.
Saeed HM, Alanazi MS, Nounou HA, et al (2013). Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population. Asian Pac J Cancer Prev, 14, 3761-8. crossref(new window)

37.
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007). Human papillomavirus and cervical cancer. Lancet, 370, 890-907. crossref(new window)

38.
Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF (2012). Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep, 39, 6647-54. crossref(new window)

39.
Sharifah NA, Seeni A, Nurismah MI, et al (2009). Prevalence of human papillomavirus in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev, 10, 303-6.

40.
Shukla D, Dinesh Kale A, Hallikerimath S, Vivekanandhan S, Venkatakanthaiah Y (2012). Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 156, 253-9. crossref(new window)

41.
Shukla RK, Tilak AR, Kumar C, et al (2013). Associations of CYP1A1, GSTM1 and GSTT1 polymorphisms with lung cancer susceptibility in a Northern Indian population. Asian Pac J Cancer Prev, 14, 3345-9. crossref(new window)

42.
Sivaraman L, Leatham MP, Yee J, et al (1994). CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res, 54, 3692-5.

43.
Smith G, Stubbins MJ, Harries LW, Wolf CR (1998). Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica, 28, 1129-65. crossref(new window)

44.
Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32. crossref(new window)

45.
Spurr NK, Gough AC, Stevenson K, Wolf CR (1987). Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res, 15, 5901. crossref(new window)

46.
Sreelekha TT, Ramadas K, Pandey M, et al (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol, 37, 593-8. crossref(new window)

47.
Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T (1999). Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol, 35, 191-6. crossref(new window)

48.
von Keyserling H, Bergmann T, Schuetz M, et al (2011). Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure. Int J Gynecol Cancer, 21, 1664-71. crossref(new window)

49.
Wang XW, Zhong TY, Xiong YH, Lin HB, Liu QY (2012). Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 3717-21. crossref(new window)

50.
Xia L, Gao J, Liu Y, Wu K (2013). Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis. Tumour Biol, 34, 223-30. crossref(new window)

51.
Yun YX, Wang YP, Wang P, et al (2013). CYP1A1 genetic polymorphisms and risk for esophageal cancer: a casecontrol study in central China. Asian Pac J Cancer Prev, 14, 6507-12. crossref(new window)

52.
Zainal Ariffin O, Nor Saleha IT (2011). National cancer registry report, Malaysia cancer statistics-data and figure 2007, National Cancer Registry, Ministry of Health, Malaysia. 42-3

53.
Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z (2012a). CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects. J Exp Clin Cancer Res, 31, 62. crossref(new window)

54.
Zhuo X, Zhao H, Chang A, et al (2012b). Quantitative assessment of CYP1A1*2A variations with oral carcinoma susceptibility: evidence from 1,438 cases and 2, 086 controls. Cancer Invest, 30, 552-9. crossref(new window)